Intrust Bank NA Sells 49 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intrust Bank NA reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,429 shares of the medical equipment provider’s stock after selling 49 shares during the period. Intrust Bank NA’s holdings in Intuitive Surgical were worth $3,878,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $31,000. Finally, Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last quarter. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Barclays lifted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $491.84 on Friday. The company has a 50 day moving average price of $556.28 and a 200-day moving average price of $532.34. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market capitalization of $175.18 billion, a PE ratio of 76.73, a PEG ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.